Deanna H. Pafundi

Deanna H. Pafundi

Auto-generated profile, based on publicly available information

Deanna H. Pafundi

Department of Radiation Oncology, Mayo Clinic, Jacksonville, FL 32224, USA

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 June 2023 in Radiotherapy and Oncology
Verified
Journal Article
Closed access
MSMaasa H. Seaberg
Maasa H. Seaberg
TKTomas Kazda
Tomas Kazda
RYRyan S. Youland
Ryan S. Youland
NLNadia N. Laack
Nadia N. Laack
DPDeanna H. Pafundi
Deanna H. Pafundi
DBDebra H. Brinkmann
Debra H. Brinkmann

3 November 2025 in Cancers
Verified
Journal Article
Open access
PDF file
JQJing Qian
Jing Qian
DHDeanna Hasenauer
Deanna Hasenauer
WBWilliam G. Breen
William G. Breen
PBPaul Brown
Paul Brown
CHChristopher Harker Hunt
Christopher Harker Hunt
DBDebra H. Brinkmann
Debra H. Brinkmann
Background: Post-treatment prognosis and monitoring are critical for determining the timing of salvage treatment in glioblastoma patients but has been challenging due to difficulties differentiating progression from treatment effects in conventional images. This exploratory study aimed to establish the correlation of radiomics image features from time series of amino acid tracer 18F-DOPA PET images, with outcomes, using machine learning and dimension reduction analysis. Methods: 18F-DOPA PET images were collected for a patient cohort with wild-type IDH and unmethylated MGMT who underwent dose-escalated radiation therapy. Quantitative features were derived from the high uptake region (T/N > 2.0) in pre- and post-radiation therapy follow-up 18F-DOPA PET images. A customized workflow was utilized for pre-selecting predictive features, followed by manifold learning. Machine learning algorithms were employed to establish associations between imaging features and remaining survival (RS), defined as the time between a follow-up scan and date of death. Results: The ML models exhibited 81–83% ROC_AUC in predicting RS evaluated on an independent test dataset. A RS map is proposed for monitoring tumor alterations through serial 18F-DOPA PET scans, demonstrating superior sensitivity and better correlation with survival compared to the RANO criteria. Conclusions: Our study demonstrates that ML models utilizing FU 18F-DOPA PET images have the potential to effectively predict future survival outcomes in patients with glioblastoma treated with dose-escalated radiation therapy. The capability to assess changes in tumor over time through imaging can potentially assist in patient stratification and the selection of salvage treatments, while also aiding in distinguishing treatment effects from genuine tumor progression.